Prevalence of transmitted drug resistance and impact of transmitted resistance on treatment success in the German HIV-1 Seroconverter Cohort (Q28475698)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	Prevalence of transmitted drug resistance and impact of transmitted resistance on treatment success in the German HIV-1 Seroconverter Cohort	scientific article

Statements

scholarly article

0 references

Prevalence of transmitted drug resistance and impact of transmitted resistance on treatment success in the German HIV-1 Seroconverter Cohort (English)

0 references

HIV transmission

0 references

Claudia Kuecherer

2

0 references

author name string

Barbara Bartmeyer

1

0 references

Claudia Houareau

3

0 references

Johanna Werning

4

0 references

Kathrin Keeren

5

0 references

Sybille Somogyi

6

0 references

Christian Kollan

7

0 references

Heiko Jessen

8

0 references

Stephan Dupke

9

0 references

Osamah Hamouda

10

0 references

language of work or name

0 references

publication date

7 October 2010

0 references

0 references

5

0 references

10

0 references

e12718

0 references

copyright license

Creative Commons Attribution 4.0 International

7 October 2010

1 reference

April 2022 Public Data File from Crossref

copyright status

0 references

Drug resistance mutations for surveillance of transmitted HIV-1 drug-resistance: 2009 update

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2951346

19 March 2017

HIV-1 transmission cluster with T215D revertant mutation among newly diagnosed patients from the Basque Country, Spain

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2951346

29 September 2017

HIV-1 drug resistance mutations: an updated framework for the second decade of HAART

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2951346

29 September 2017

Consensus drug resistance mutations for epidemiological surveillance: basic principles and potential controversies.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2951346

29 September 2017

Antiretroviral drug resistance testing in adult HIV-1 infection: 2008 recommendations of an International AIDS Society-USA panel

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2951346

29 September 2017

Durability and outcome of initial antiretroviral treatments received during 2000--2005 by patients in the Swiss HIV Cohort Study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2951346

29 September 2017

Class-sparing regimens for initial treatment of HIV-1 infection

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2951346

29 September 2017

Transmission of drug-resistant HIV-1 in Europe remains limited to single classes

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2951346

29 September 2017

Impact of transmission of drug-resistant HIV on the course of infection and the treatment success. Data from the German HIV-1 Seroconverter Study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2951346

29 September 2017

Update of the drug resistance mutations in HIV-1: 2007.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2951346

29 September 2017

Prevalence and determinants of transmitted antiretroviral drug resistance in HIV-1 infection

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2951346

29 September 2017

Non-nucleoside reverse transcriptase inhibitors: a review

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2951346

29 September 2017

Clinical implications of HIV drug resistance to nucleoside and nucleotide reverse transcriptase inhibitors

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2951346

29 September 2017

Epidemiology of antiretroviral drug resistance in drug-naïve persons

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2951346

29 September 2017

HIV-1 protease and reverse transcriptase mutations for drug resistance surveillance

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2951346

29 September 2017

Prevalence of drug-resistant HIV-1 variants in untreated individuals in Europe: implications for clinical management

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2951346

29 September 2017

Diversity of thymidine analogue resistance genotypes among newly diagnosed HIV-1-infected persons

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2951346

29 September 2017

Declining trend in transmission of drug-resistant HIV-1 in Amsterdam

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2951346

29 September 2017

Transmitted human immunodeficiency virus type 1 carrying the D67N or K219Q/E mutation evolves rapidly to zidovudine resistance in vitro and shows a high replicative fitness in the presence of zidovudine

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2951346

29 September 2017

Risk of failure in patients with 215 HIV-1 revertants starting their first thymidine analog-containing highly active antiretroviral therapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2951346

29 September 2017

HIV-1 drug resistance: can we overcome?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2951346

29 September 2017

Time trends in primary HIV-1 drug resistance among recently infected persons

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2951346

29 September 2017

The incidence of multidrug and full class resistance in HIV-1 infected patients is decreasing over time (2001-2006) in Portugal

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2951346

2 June 2018

Antiretroviral-drug resistance among patients recently infected with HIV.

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0012718

21 January 2018

Transmission of HIV-1 drug resistance in Switzerland: a 10-year molecular epidemiology survey

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0012718

21 January 2018

HIV treatment decisions and transmitted drug resistance.

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0012718

21 January 2018

Plasma HIV RNA Decline and Emergence of Drug Resistance Mutations among Patients with Multiple Virologic Failures Receiving Resistance Testing-Guided HAART

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0012718

21 January 2018

Primary HIV drug resistance and efficacy of first-line antiretroviral therapy guided by resistance testing

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0012718

21 January 2018

Impact of medical and nonmedical factors on physician decision making for HIV/AIDS antiretroviral treatment

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0012718

21 January 2018

Decline in the rate of genotypic resistance to antiretroviral drugs in recent HIV seroconverters in Madrid

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0012718

21 January 2018

Evidence of a decline in transmitted HIV-1 drug resistance in the United Kingdom

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0012718

21 January 2018

Diminished representation of HIV-1 variants containing select drug resistance-conferring mutations in primary HIV-1 infection

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0012718

21 January 2018

Evolving patterns of HIV-1 resistance to antiretroviral agents in newly infected individuals

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0012718

21 January 2018

Long-term persistence of primary genotypic resistance after HIV-1 seroconversion.

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0012718

21 January 2018

Persistence of a sexually transmitted highly resistant HIV-1: pol quasispecies evolution over 33 months in the absence of treatment.

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0012718

21 January 2018

Tracking the prevalence of transmitted antiretroviral drug-resistant HIV-1: a decade of experience

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0012718

21 January 2018

Frequency of genotypic and phenotypic drug-resistant HIV-1 among therapy-naive patients of the German Seroconverter Study.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2951346

27 November 2018

An elusive soluble suppressor

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0012718

21 January 2018

Changing rates and patterns of drug resistance mutations in antiretroviral-experienced HIV-infected patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/20949104

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Trends of prevalence of primary HIV drug resistance in Germany

1 reference

https://pubmed.ncbi.nlm.nih.gov/20949104

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Long-term adherence to first-line highly active antiretroviral therapy in a hospital-based cohort: predictors and impact on virologic response and relapse

1 reference

https://pubmed.ncbi.nlm.nih.gov/20949104

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

[Epidemiology of primary drug resistance in chronically HIV-infected patients in Nordrhein-Westfalen, Germany, 2001-2005]

1 reference

https://pubmed.ncbi.nlm.nih.gov/20949104

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Update of the drug resistance mutations in HIV-1: Spring 2008

1 reference

https://pubmed.ncbi.nlm.nih.gov/20949104

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1371/JOURNAL.PONE.0012718

1 reference

Consolidated OpenCitations Corpus – April 2017

OpenCitations bibliographic resource ID

2010PLoSO...512718B

0 references

OpenCitations bibliographic resource ID

1 reference

Consolidated OpenCitations Corpus – April 2017

OpenCitations bibliographic resource ID

PMC publication ID

1 reference

Consolidated OpenCitations Corpus – April 2017

OpenCitations bibliographic resource ID

PubMed publication ID

1 reference

Consolidated OpenCitations Corpus – April 2017

OpenCitations bibliographic resource ID

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q28475698&oldid=1869955656"